Recently, stocks related to the 'Helicobacter pylori' concept surged. On the news front, the U.S. Department of Health and Human Services recently released the 15th edition of the carcinogen report, adding eight new substances, including chronic Helicobacter pylori infection, which is now classified as a confirmed carcinogen.
Among the companies with surging stock prices in the 'Helicobacter pylori concept' group, aside from those producing treatments for Helicobacter pylori, many are involved in probiotic products. Juneyao Health, which saw its stock price jump, held a global product launch in Shanghai on November 12, 2021, where it partnered with Jiangnan University to introduce an innovative yogurt-based active probiotic product. One of the products, named 'Qing You Jun,' claims to contain the nationally patented strain CCFM1118, a type of Lactobacillus crispatus that can prevent and/or treat Helicobacter pylori infections.
E-commerce platforms easily yield search results for 'Helicobacter pylori toothpaste'
Searches across major e-commerce platforms reveal that daily necessities and health supplements targeting Helicobacter pylori also appear to be popular. For example, several toothpastes linked to Helicobacter pylori have garnered 'over 100,000 repeat customers.' Some imported probiotic health supplements claim to be 'Hp-clearing tablets,' able to identify and eliminate Helicobacter pylori. On one platform, a live stream on the morning of January 7 was selling Helicobacter pylori toothpaste, with official customer service responding that if there’s an Hp infection, it can be treated, and if not, it can be prevented.
Helicobacter pylori primarily spreads through oral-oral transmission and is highly contagious. Public data indicates that the overall infection rate of Helicobacter pylori in China is approximately 50%. There is significant market demand for Helicobacter pylori prevention and treatment, but...